galectin-3/-9 antagonists (GlycoMimetics)

N/A

Report date: 2025/03/20 15:49:33

NME

Base Information

Drug Namegalectin-3/-9 antagonists (GlycoMimetics)

Drug Alias Namedual LAG-3 checkpoint inhibitor/TIM-3 checkpoint inhibitor (Xencor)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsGalactoside-binding lectin Galectin 9 blockersHepatitis A virus cellular receptor 2 inhibitors +[4]

TargetsGalactoside-binding lectin Galectin 9Hepatitis A virus cellular receptor 2Lymphocyte activation gene 3 protein +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCrescent Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesCrescent Biopharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A